Complications from "Stem Cell Tourism" in Neurology
- PMID: 32632977
- DOI: 10.1002/ana.25842
Complications from "Stem Cell Tourism" in Neurology
Abstract
"Stem cell tourism," the practice of offering unproven cellular preparations to patients as approved therapy, is rising in neurology. Currently, the experiences of patients and reported complications from these procedures are unknown in the United States. We evaluate academic neurologists' experiences with stem cell tourism and assess perceived competency on discussing this topic with patients. We found a lack of neurologist preparedness to discuss stem cell therapies with patients and an alarming list of unreported complications from these unregulated procedures. We also identified an urgent need for neurologist education and the creation of a national registry for reporting patient complications resulting from experimental stem cell interventions. ANN NEUROL 2020;88:661-668.
© 2020 American Neurological Association.
References
-
- Turner L, Knoepfler P. Selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell 2016;19:154-157.
-
- Bowman M, Racke M, Kissel J, Imitola J. Responsibilities of health care professionals in counseling and educating patients with incurable neurological diseases regarding "stem cell tourism": caveat emptor. JAMA Neurol 2015;72:1342-1345.
-
- Julian K, Yuhasz N, Hollingsworth E, Imitola J. The "growing" reality of the neurological complications of global "stem cell tourism". Semin Neurol 2018;38:176-181.
-
- Ogbogu U, Rachul C, Caulfield T. Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better? Regen Med 2013;8:361-369.
-
- Kamenova K, Reshef A, Caulfield T. Representations of stem cell clinics on twitter. Stem Cell Rev Rep 2014;10:753-760.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
